22 results
S-1/A
EX-10.2
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
.
10. Data Privacy Consent. In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its … privacy rights the Optionee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit
S-3
EX-1.2
CADL
Candel Therapeutics Inc
5 Aug 22
Shelf registration
5:08pm
authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection … of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification.
(qq) Compliance with Data Privacy Laws. The Company
S-1/A
EX-1.1
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy … or modification.
(qq) Compliance with Data Privacy Laws. The Company and its subsidiaries are, and at all prior times were, in material compliance with all
CORRESP
CADL
Candel Therapeutics Inc
7 Jul 21
Correspondence with SEC
12:00am
of Freedom of Information and Privacy Act Operations in connection with the confidential treatment request, pursuant to Rule 83 of the Commission’s Rules … of Information and Privacy Act Operations.
We confirm on behalf of the Company that, prior to circulating copies of the preliminary prospectus
10-Q
4y0eumxx dnpmw4l
8 Sep 21
Quarterly report
8:37am
S-1/A
wabvz76
16 Jul 21
IPO registration (amended)
6:07am
S-1
7f2k1n77jh50azo5wzd
25 Jun 21
IPO registration
5:28pm
DRS/A
l6gw6bix40hg9402kw
31 Mar 21
Draft registration statement (amended)
12:00am
424B4
ltpori3cg3 kf
28 Jul 21
Prospectus supplement with pricing info
4:02pm